|
|
||||||||
J. Biol. Chem., Vol. 262, Issue 14, 6605-6609, 05, 1987
DM Turner and JB Walker
Breast muscle of young chicks fed chow diets containing the creatine analog
1-carboxymethyl-2-iminoimidazolidine (cyclocreatine) accumulated up to 40
mumol/g wet weight of the synthetic phosphagen 1-carboxymethyl-
2-imino-3-phosphonoimidazolidine (cyclocreatine-P2-). ATP levels were
sustained at high values substantially longer in breast muscle of
cyclocreatine-fed chicks, compared to control-fed chicks, during total
ischemia initiated 2 h after injection of both groups with the beta-
adrenergic agonist isoproterenol (5 mg/kg subcutaneous). For example, in
chicks fed 0.5% cyclocreatine for 10-19 days ATP levels in
isoproterenol-stimulated breast muscles after 1 h of ischemia at 37 degrees
C were 6.1 mumol/g, compared to 1.9 mumol/g for the control-fed group, and
after 2 h of ischemia were 3.5 mumol/g compared to 0.6 mumol/g for
controls. Creatine-P reserves in isoproterenol-stimulated breast muscles of
all dietary groups were essentially exhausted within the first hour of
ischemia. In contrast, breast muscle of chicks fed either 1 or 0.5%
cyclocreatine still contained 28 and 19 mumol/g of cyclocreatine-P,
respectively, after 1 h of ischemia; after 2 h of ischemia, the respective
cyclocreatine-P values were 20 and 13 mumol/g. Isoproterenol-stimulated
chick breast muscle provides the first skeletal muscle model system for
studying the molecular mechanisms by which dietary cyclocreatine helps
sustain ATP levels during ischemia. Although adaptive factors are also
involved, it is suggested that a significant portion of the ATP-sustaining
activity of dietary cyclocreatine in ischemic breast muscle can be
attributed to the unique thermodynamic properties of the accumulated
cyclocreatine-P. These properties enable cyclocreatine-P to continue to
thermodynamically buffer the adenylate system and transport high energy
phosphate throughout the long muscle fibers at cytosolic pH values and
phosphorylation potentials well below the range where the creatine-P system
can function effectively. Synergism between glycolysis and this long-acting
synthetic phosphagen might well help delay depletion of ATP levels in
skeletal muscles during ischemia. Cyclocreatine feeding provides a unique
experimental tool for quantitative evaluation of the proposed protective
role of ATP against irreversible cellular damage in skeletal and cardiac
muscles during ischemic episodes.
Enhanced ability of skeletal muscle containing cyclocreatine phosphate to sustain ATP levels during ischemia following beta-adrenergic stimulation
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Wyss and R. Kaddurah-Daouk Creatine and Creatinine Metabolism Physiol Rev, July 1, 2000; 80(3): 1107 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Matthews, L. Yang, B. G. Jenkins, R. J. Ferrante, B. R. Rosen, R. Kaddurah-Daouk, and M. F. Beal Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington's Disease J. Neurosci., January 1, 1998; 18(1): 156 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Wiseman and M. J. Kushmerick Creatine Kinase Equilibration Follows Solution Thermodynamics in Skeletal Muscle J. Biol. Chem., May 26, 1995; 270(21): 12428 - 12438. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |